|
Meso Scale Diagnostics LLC
two-site monoclonal antibody (mab)-based sandwich elisa assays Two Site Monoclonal Antibody (Mab) Based Sandwich Elisa Assays, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/us09938263-758-23-46?v=Meso+Scale+Diagnostics+LLC Average 90 stars, based on 1 article reviews
two-site monoclonal antibody (mab)-based sandwich elisa assays - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Bachem
i31e/e22g β 42 ![]() I31e/E22g β 42, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc02856165-66-12-29?v=Bachem Average 90 stars, based on 1 article reviews
i31e/e22g β 42 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
JPT Peptide Technologies GmbH
aβ42 variants (wild type, a2t and a2v mutants, purity >95% by hplc/c18) ![]() Aβ42 Variants (Wild Type, A2t And A2v Mutants, Purity >95% By Hplc/C18), supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc04223304-81-2-20?v=JPT+Peptide+Technologies+GmbH Average 90 stars, based on 1 article reviews
aβ42 variants (wild type, a2t and a2v mutants, purity >95% by hplc/c18) - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
InContext Inc
ad csf biomarkers ![]() Ad Csf Biomarkers, supplied by InContext Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pm40551285-29-14-23?v=InContext+Inc Average 90 stars, based on 1 article reviews
ad csf biomarkers - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
BIOTAGE
the fragment peptides of e22p-aβ42 ![]() The Fragment Peptides Of E22p Aβ42, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc06237870-368-4-27?v=BIOTAGE Average 90 stars, based on 1 article reviews
the fragment peptides of e22p-aβ42 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Creoptix Inc
aβ42 peptide (20 ug/ml in na acetate ph 4.5) ![]() Aβ42 Peptide (20 Ug/Ml In Na Acetate Ph 4.5), supplied by Creoptix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pm39382238-290-0-18?v=Creoptix+Inc Average 90 stars, based on 1 article reviews
aβ42 peptide (20 ug/ml in na acetate ph 4.5) - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Peptide Specialty Laboratories
aβ42 g33a peptides ![]() Aβ42 G33a Peptides, supplied by Peptide Specialty Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc03098494-243-16-19?v=Peptide+Specialty+Laboratories Average 90 stars, based on 1 article reviews
aβ42 g33a peptides - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
aβ42 peptides with a substitution of arg5 to gly (r5g) ![]() Aβ42 Peptides With A Substitution Of Arg5 To Gly (R5g), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc09673141-265-4-20?v=ABclonal+Biotechnology Average 90 stars, based on 1 article reviews
aβ42 peptides with a substitution of arg5 to gly (r5g) - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
ChinaPeptide Co Ltd
synthetic human aβ (1-42) peptides aβ42 ![]() Synthetic Human Aβ (1 42) Peptides Aβ42, supplied by ChinaPeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc08741852-44-0-9?v=ChinaPeptide+Co+Ltd Average 90 stars, based on 1 article reviews
synthetic human aβ (1-42) peptides aβ42 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Braincare Inc
fitc-aβ42 peptide ![]() Fitc Aβ42 Peptide, supplied by Braincare Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc10916500__sj___pdf___1___aja___10__1177_15333175241236251-43-6-15?v=Braincare+Inc Average 90 stars, based on 1 article reviews
fitc-aβ42 peptide - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
NeurOp Inc
aβ42 peptide ![]() Aβ42 Peptide, supplied by NeurOp Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pm38673907-76-12-0?v=NeurOp+Inc Average 90 stars, based on 1 article reviews
aβ42 peptide - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Gendanio Inc
aβ42 peptides ![]() Aβ42 Peptides, supplied by Gendanio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a%CE%B242+peptides/pmc08657612-153-0-5?v=Gendanio+Inc Average 90 stars, based on 1 article reviews
aβ42 peptides - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal:
Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
doi: 10.1016/j.bpj.2009.12.4320
Figure Lengend Snippet: Measuring the neurotoxicity of Aβ mutants by their effect on fly longevity. (A) The average neurotoxicity (Stox) of a single line of flies expressing E22G Aβ42 (○) compared with that of two independent lines of flies expressing I31E/E22G Aβ42 (□ and ♢), one line of WT Aβ40 (Δ), and one line of WT Aβ42 (+). (B) The average neurotoxicity of a single line of flies expressing WT Aβ40 (○) or WT Aβ42 (♢) compared with those of two independent lines of flies expressing E3R Aβ40 (□ and Δ); 100 flies divided equally into 10 tubes were analyzed for each line. Stox for each tube (n = 10 flies per tube) was calculated from the median survival determined by Kaplan-Meier survival analysis (see Materials and Methods). Differences between lines (n = 10 tubes) were analyzed for significance using the Mann Whitney U-test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).
Article Snippet: The A β peptides A β 40 , A β 42 ,
Techniques: Expressing, MANN-WHITNEY
Journal:
Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
doi: 10.1016/j.bpj.2009.12.4320
Figure Lengend Snippet: Predicted aggregation propensity scores
Article Snippet: The A β peptides A β 40 , A β 42 ,
Techniques:
Journal:
Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
doi: 10.1016/j.bpj.2009.12.4320
Figure Lengend Snippet: Aggregation propensity profiles of Aβ40 (solid line) and E22G Aβ42 (dashed line), indicating the locations in negative peaks of the two mutants studied here (E3R Aβ40 and I31E/E22G Aβ40).
Article Snippet: The A β peptides A β 40 , A β 42 ,
Techniques:
Journal:
Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
doi: 10.1016/j.bpj.2009.12.4320
Figure Lengend Snippet: Measurement of the kinetics of aggregation and the types of aggregates formed by Aβ40, E22G Aβ42, and their mutants. (A) Progression of the aggregation reactions for E22G Aβ42 (solid circles) and E22G/I31E Aβ42 (open circles) monitored by ThT fluorescence spectroscopy. (B) The progression of the aggregation reactions for Aβ40 (solid squares) and E3R Aβ40 (open squares) was monitored by ThT fluorescence spectroscopy. (C and D) Transmission electron micrographs of samples from the end points of the E22G Aβ42 and I31E/E22G Aβ42 aggregation reactions shown in A indicate that fibrils were formed by both peptides. (E and F) Transmission electron micrographs of samples from the end points of the Aβ40 and E3R Aβ40 aggregation reactions shown in B indicate that fibrils were formed by both peptides. Scale bar = 200 μm.
Article Snippet: The A β peptides A β 40 , A β 42 ,
Techniques: Fluorescence, Spectroscopy, Transmission Assay
Journal:
Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide
doi: 10.1016/j.bpj.2009.12.4320
Figure Lengend Snippet: Time-course analysis by TEM of the aggregation of E22G Aβ42 and I31E/E22G Aβ42. (A–C) TEM images taken throughout the aggregation reaction of E22G Aβ42 (t = 0 min, 15 min, and 6 days, respectively). (D–F) TEM images taken throughout the aggregation reaction of I31E/E22G Aβ42 (0 min, 15 min, and 6 days, respectively). Scale bar = 200 nm. (G) The size distributions of aggregates of E22G Aβ42 (solid line) and E22G/I31E Aβ42 (dashed line) determined by SEC performed immediately after dissolution of the peptides.
Article Snippet: The A β peptides A β 40 , A β 42 ,
Techniques:
Journal: Scientific Reports
Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques
doi: 10.1038/s41598-018-35004-3
Figure Lengend Snippet: Characterization of immunoreactivity of 11A1 antibody. ( A ) Assessment of the binding affinity of 11A1 antibody against various synthetic Aβ peptides. E22P-Aβ42 (green), E22P-Aβ9-35ox (black), E22P-Aβ11-35ox (red), E22P-Aβ16-35ox (blue), and E22P-Aβ11-34 (orange) were synthesized and the binding affinity of 11A1 antibody for each peptide was assessed by Enzyme immunoassay. The 11A1 antibody exhibited high binding affinity for E22P-Aβ42 and E22P-Aβ9-35ox. Data are expressed as mean ± SD of three independent measurements. ( B ) Comparison of 11A1 antibody staining pattern with that of 6E10, 4G8, and OC antibodies. Postmortem human frontal cortex sections of an Alzheimer’s disease patient were stained with 6E10 (left panel), 4G8 (center left panel), OC (center right panel) and 11A1 (right panel) antibodies. Senile plaques (arrow heads) and vascular amyloid (arrows) are identified by 11A1 antibody with a similar pattern to that of the other three Aβ antibodies. The images were taken under 20x objective lens. Scale bar 50 µm. ( C and D) Assessment of 11A1 cross-reactivity against APP. Histological sections of human cingulate gyrus with traumatic axonal injury were stained with 22C11 (APP antibody) (left panel) and 11A1 (right panel) antibodies. The traumatic axonal balloons display intense signal with the antibody for APP (arrowheads), but these lesions are not stained with 11A1 antibody. ( C ) The images were taken under 20x objective lens. Scale bar 50 µm. ( D ) The images were taken under 40x objective lens. Scale bar 20 µm. ( E ) Testing 11A1 antibody specificity for Aβ toxic conformer in senile plaques and blood vessels. 11A1 antibody was pre-incubated without (left panel) or with (right panel) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the signal in senile plaques and blood vessels. The images were taken under 20x objective lens. Scale bar 50 µm.
Article Snippet: The fragment peptides of
Techniques: Binding Assay, Synthesized, Enzyme-linked Immunosorbent Assay, Staining, Incubation
Journal: Scientific Reports
Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques
doi: 10.1038/s41598-018-35004-3
Figure Lengend Snippet: 11A1 immunoreactivity in pericapillary spaces. ( A and B ) Representative images were obtained under 63x objective lens. Pericapillary spaces in inferior parietal cortex, layer V, immunostained with 11A1 and Collagen IV. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. Left panels show the 11A1 signal, middle panels indicate the Collagen IV signal and right panels show merged images. ( A ) Capillary cross sections, ( B ) capillary longitudinal sections. Scale bars ( A and B) , 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in pericapillary space of the three age groups. The 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal around Collagen IV signal (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of pericapillary spaces labeled with 11A1 in measured area across age-spectrum (30-65 years). The relationship with age is not statistically significant before age 45 (p = 0.82), but it becomes highly significant after age 45 (p = 0.0006) by the Piecewise regression. ( E ) Number of cross sectional pericapillary spaces in measured area across age-spectrum (30–65 years). There is no significant change in the number of cross sectional capillary pericapillary spaces with age ( P = 0.496).
Article Snippet: The fragment peptides of
Techniques: Incubation, Labeling
Journal: Scientific Reports
Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques
doi: 10.1038/s41598-018-35004-3
Figure Lengend Snippet: 11A1 immunoreactivity in neurons. ( A and B ) Representative images were obtained under 63x objective lens. Cortical neurons of inferior parietal cortex, layer V, co-stained with 11A1 and MAP2 antibodies and 11A1, MAP2 and Cathepsin D antibodies. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. ( A ) Left panels show the 11A1 signal (green), middle panels indicate MAP2 signal (red) and right panels show merged images. Scale bar 5 µm. ( B ) Left panels show the 11A1 signal, middle panels indicate Cathepsin D signal and right panels show merged images. The white contours in the merged images indicates the cell shape identified by MAP2. Intracellular 11A1 immunoreactivity (green) partially colocalized with Cathepsin D signal (Magenta). Scale bar 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in neurons of the three age groups. 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissue sections with the primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal (green) in and around MAP2 signals (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of cortical neurons labeled with 11A1 in measured area across the age-spectrum (30–65 years). The relationship with age is not significant (p = 0.807). ( E ) Number of neurons in measured area across the age-spectrum (30–65 years). There is no significant change in the number of neurons with age (p = 0.6061).
Article Snippet: The fragment peptides of
Techniques: Staining, Incubation, Labeling
Journal: Scientific Reports
Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques
doi: 10.1038/s41598-018-35004-3
Figure Lengend Snippet: 11A1 immunoreactivity in protoplasmic astrocytes. ( A and B ) Representative images were obtained under 63x objective lens. Protoplasmic astrocytes of human inferior parietal cortex, layer V, immunostained with 11A1 and ALDH1L1 antibodies and 11A1, GFAP and Cathepsin D antibodies. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. (A) Left panels show the 11A1 signal (green), middle panels correspond to the ALDH1L1 signal (red) and right panels show the merged images. Scale bar 5 µm. ( B ) Left panels show the 11A1 signal, middle panels correspond to the Cathepsin D signal (magenta) and right panels show the merged images. The white contours in the merged images indicate the cell shape identified by GFAP. Separate localization of the 11A1 immunoreactivity and Cathepsin D signals in the astrocytes is demonstrated. Scale bar 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in protoplasmic astrocytes of the three age groups. The 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissue sections with primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal (green) in and around ALDH1L1 signal (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of protoplasmic astrocytes labeled with 11A1 of the astrocytes in measured area across the age-spectrum (30–65 years). The percentage of 11A1 labeled astrocytes gradually increases by age (p = 0.020). ( E ) Number of the astrocytes in measured area across the age-spectrum (30–65 years). Number of astrocytes gradually increases by age (p = 0.014).
Article Snippet: The fragment peptides of
Techniques: Incubation, Labeling
Journal: ACS Chemical Neuroscience
Article Title: Key Residue for Aggregation of Amyloid-β Peptides
doi: 10.1021/acschemneuro.2c00358
Figure Lengend Snippet: Dimerization propensities of Aβ42 (green) and Aβ40 (red).
Article Snippet: The synthetic Aβ42 and
Techniques:
Journal: ACS Chemical Neuroscience
Article Title: Key Residue for Aggregation of Amyloid-β Peptides
doi: 10.1021/acschemneuro.2c00358
Figure Lengend Snippet: Intermolecular contact probabilities of C α atoms for (a) Aβ42 and (b) Aβ40. Probabilities with which the residues in (c) Aβ42 and (d) Aβ40 form β-strands with the corresponding length.
Article Snippet: The synthetic Aβ42 and
Techniques:
Journal: ACS Chemical Neuroscience
Article Title: Key Residue for Aggregation of Amyloid-β Peptides
doi: 10.1021/acschemneuro.2c00358
Figure Lengend Snippet: Intramolecular contact probabilities of C α atoms for (a) Aβ42 and (b) Aβ40. Probability distributions with respect to the number of intramolecular and intermolecular β-bridges for (c) Aβ42 and (d) Aβ40.
Article Snippet: The synthetic Aβ42 and
Techniques:
Journal: ACS Chemical Neuroscience
Article Title: Key Residue for Aggregation of Amyloid-β Peptides
doi: 10.1021/acschemneuro.2c00358
Figure Lengend Snippet: Free-energy landscapes for (a) Aβ42 and (b) Aβ40 with respect to the corresponding first and second principal components (PC1 and PC2). The local-minimum free-energy states are labeled as (a) states A–E for Aβ42 and (b) states A′–E′ for Aβ40. The units of the free-energy landscapes are kcal/mol. Representative dimer structures in (a) states A–E and (b) states A′–E′ are also shown.
Article Snippet: The synthetic Aβ42 and
Techniques: Labeling
Journal: ACS Chemical Neuroscience
Article Title: Key Residue for Aggregation of Amyloid-β Peptides
doi: 10.1021/acschemneuro.2c00358
Figure Lengend Snippet: Intramolecular contact probabilities between residues for (a) Aβ42 and (b) Aβ40. Here, all atoms, including the side-chain atoms, except the hydrogen atoms, are considered in calculating the contact probabilities. (c) Schematic illustration where the β-hairpin of Aβ42 is stabilized by the contacts between the C-terminus and Arg5 and between E22 and K28.
Article Snippet: The synthetic Aβ42 and
Techniques:
Journal: ACS Chemical Neuroscience
Article Title: Key Residue for Aggregation of Amyloid-β Peptides
doi: 10.1021/acschemneuro.2c00358
Figure Lengend Snippet: Intermolecular contact probabilities between residues for (a) Aβ42 and (b) Aβ40. Here, all atoms, including the side-chain atoms, except the hydrogen atoms, are considered in calculating the contact probabilities.
Article Snippet: The synthetic Aβ42 and
Techniques:
Journal: International Journal of Molecular Sciences
Article Title: Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer’s Disease
doi: 10.3390/ijms222312760
Figure Lengend Snippet: The aggregation of Aβ42 into Aβ fibrils. ( a ) The fluorescence intensity of ThT was obtained by incubation of Aβ42 (Aβ; blue line), Aβ42 mixed with BSP (Aβ-BSP; red line) in PBS at 37 °C for 14 days. The green line represents the fluorescence intensity of ThT in PBS only (PBS). ( b ) The TEM image of Aβ42 monomers without aggregation on day 0; ( c ) the Aβ42 aggregated into thick and compact Aβ fibrils on day 7; ( d ) BSP reduced aggregation of Aβ42 with reduced thickness and loose packing of Aβ fibrils on day 7. The scale bar is 0.2 μm. ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).
Article Snippet:
Techniques: Fluorescence, Incubation, Control
Journal: International Journal of Molecular Sciences
Article Title: Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer’s Disease
doi: 10.3390/ijms222312760
Figure Lengend Snippet: The LIVE/DEAD staining of N2a cells in ( a ) the control: cells cultured in medium only, ( b ) positive control: cells treated with zinc diethyldithiocarbamate, ( c ) negative control: cells treated with aluminum oxide, ( d ) BSP: cells treated with an extracted solution of BSP, and ( e ) Aβ-BSP: cells treated with Aβ42 and BSP. ( f ) Quantitative results of survival rate in N2a cells. *** p < 0.001 compared with control.
Article Snippet:
Techniques: Staining, Control, Cell Culture, Positive Control, Negative Control
Journal: International Journal of Molecular Sciences
Article Title: Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer’s Disease
doi: 10.3390/ijms222312760
Figure Lengend Snippet: Antioxidant activity of extracted BSP. DCFDA was used to measure the intracellular ROS in N2a cells without any treatment (control), treated with Aβ42 (Aβ), and Aβ42 and BSP (Aβ42-BSP). ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).
Article Snippet:
Techniques: Antioxidant Activity Assay, Control